par Hougardy, Jean-Michel 
;Broeders, Emine Nilufer ;Kianda, Mireille N;Massart, Annick ;Madhoun, Philippe;Le Moine, Alain ;Hoang, Anh Dung ;Mikhalski, Dimitri ;Wissing, Karl Martin ;Abramowicz, Daniel
Référence Transplantation, 91, 5, page (566-569)
Publication Publié, 2011-03
;Broeders, Emine Nilufer ;Kianda, Mireille N;Massart, Annick ;Madhoun, Philippe;Le Moine, Alain ;Hoang, Anh Dung ;Mikhalski, Dimitri ;Wissing, Karl Martin ;Abramowicz, Daniel Référence Transplantation, 91, 5, page (566-569)
Publication Publié, 2011-03
Article révisé par les pairs
| Résumé : | Advagraf is a slow release form of tacrolimus with once-daily formulation. The potential advantages of Advagraf are better adherence and a safer profile by avoiding toxic peak concentrations. In this study, we evaluated the required daily doses of tacrolimus and subsequent blood levels on conversion from Prograf to Advagraf among kidney transplant recipients. |
